Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome-Reference-Cited by-同舟云学术

Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome

Published:2013-10 Issue:5 Volume:13 Page:568-574
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Tsimberidou Apostolia M.,Wierda William G.,Wen Sijin,Plunkett William,O'Brien Susan,Kipps Thomas J.,Jones Jeffrey A.,Badoux Xavier,Kantarjian Hagop,Keating Michael J.

Funder

Sanofi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference26 articles.

1. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia;Richter;Am J Pathol,1928

2. Richter syndrome: biology, incidence, and therapeutic strategies;Tsimberidou;Cancer,2005

3. Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation;Tsimberidou;J Clin Oncol,2006

4. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP);Velasquez;Blood,1988

5. Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation;Press;J Clin Oncol,1991

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological management of chronic lymphocytic leukemia: current and emerging therapies;Expert Opinion on Pharmacotherapy;2024-09-08

2. Advances in the understanding of molecular genetics and therapy of Richter transformation in chronic lymphocytic leukemia;Leukemia & Lymphoma;2024-09-02

3. SOHO State of the Art Updates and Next Questions | Contemporary Standard of Care Therapy for Richter's Transformation and Future Directions;Clinical Lymphoma Myeloma and Leukemia;2024-07

4. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia;Blood Advances;2024-05-17

5. Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon;Expert Review of Hematology;2024-05-03